Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. BIOAF


Primary Symbol: V.BTI

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Post by beenthereon Mar 23, 2024 8:27am
113 Views
Post# 35948590

Agoracom Post

Agoracom PostPoster KOO-KOO2 posted this:


Halt-Nature of Default-SEDAR:

"The reporting issuer has failed to file the following continuous disclosure prescribed by securities laws:

 -annual financial statements;  
 -interim financial statements;
 -annual or interim management’s discussion and analysis (MD&A) or annual or  
 -interim management report of fund performance (MRFP);   
 -certification of annual or interim filings under Multilateral Instrument 52-109       
 -Certification of Disclosure in Issuers’ Annual and Interim Filings (MI 52-109)"
 

<< Previous
Bullboard Posts
Next >>